Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 17


Secondary Bacterial Infections Associated with Influenza Pandemics.

Morris DE, Cleary DW, Clarke SC.

Front Microbiol. 2017 Jun 23;8:1041. doi: 10.3389/fmicb.2017.01041. eCollection 2017. Review.


IL-2 Expression and T lymphocyte Phenotyping in Young Children Suffering from Upper Respiratory Tract Infection with Streptococcus Pyogenes.

Guadalupe Ramirez-Valles E, Dayali Gutierrez-Martinez V, Cervantes-Flores M, Ruiz-Baca E, Alvarado-Esquivel C.

Int J Biomed Sci. 2016 Jun;12(2):53-7.


The Association between Invasive Group A Streptococcal Diseases and Viral Respiratory Tract Infections.

Herrera AL, Huber VC, Chaussee MS.

Front Microbiol. 2016 Mar 21;7:342. doi: 10.3389/fmicb.2016.00342. eCollection 2016. Review.


Molecular and genomic characterization of pathogenic traits of group A Streptococcus pyogenes.

Hamada S, Kawabata S, Nakagawa I.

Proc Jpn Acad Ser B Phys Biol Sci. 2015;91(10):539-59. doi: 10.2183/pjab.91.539. Review.


Streptococcus pyogenes and re-emergence of scarlet fever as a public health problem.

Wong SS, Yuen KY.

Emerg Microbes Infect. 2012 Jul;1(7):e2. doi: 10.1038/emi.2012.9. Epub 2012 Jul 11. Review.


Vaccination against the M protein of Streptococcus pyogenes prevents death after influenza virus: S. pyogenes super-infection.

Klonoski JM, Hurtig HR, Juber BA, Schuneman MJ, Bickett TE, Svendsen JM, Burum B, Penfound TA, Sereda G, Dale JB, Chaussee MS, Huber VC.

Vaccine. 2014 Sep 8;32(40):5241-9. doi: 10.1016/j.vaccine.2014.06.093. Epub 2014 Jul 29.


Engagement of NKG2D on bystander memory CD8 T cells promotes increased immunopathology following Leishmania major infection.

Crosby EJ, Goldschmidt MH, Wherry EJ, Scott P.

PLoS Pathog. 2014 Feb 27;10(2):e1003970. doi: 10.1371/journal.ppat.1003970. eCollection 2014 Feb.


Inactivated and live, attenuated influenza vaccines protect mice against influenza: Streptococcus pyogenes super-infections.

Chaussee MS, Sandbulte HR, Schuneman MJ, Depaula FP, Addengast LA, Schlenker EH, Huber VC.

Vaccine. 2011 May 12;29(21):3773-81. doi: 10.1016/j.vaccine.2011.03.031. Epub 2011 Apr 8.


Intervention strategies for an influenza pandemic taking into account secondary bacterial infections.

Handel A, Longini IM Jr, Antia R.

Epidemics. 2009 Sep;1(3):185-95. doi: 10.1016/j.epidem.2009.09.001.


A mouse model of lethal synergism between influenza virus and Haemophilus influenzae.

Lee LN, Dias P, Han D, Yoon S, Shea A, Zakharov V, Parham D, Sarawar SR.

Am J Pathol. 2010 Feb;176(2):800-11. doi: 10.2353/ajpath.2010.090596. Epub 2009 Dec 30.


Rhinovirus disrupts the barrier function of polarized airway epithelial cells.

Sajjan U, Wang Q, Zhao Y, Gruenert DC, Hershenson MB.

Am J Respir Crit Care Med. 2008 Dec 15;178(12):1271-81. doi: 10.1164/rccm.200801-136OC. Epub 2008 Sep 11.


Filamentous influenza A virus infection predisposes mice to fatal septicemia following superinfection with Streptococcus pneumoniae serotype 3.

Speshock JL, Doyon-Reale N, Rabah R, Neely MN, Roberts PC.

Infect Immun. 2007 Jun;75(6):3102-11. Epub 2007 Apr 2.


Increased susceptibility to bacterial superinfection as a consequence of innate antiviral responses.

Navarini AA, Recher M, Lang KS, Georgiev P, Meury S, Bergthaler A, Flatz L, Bille J, Landmann R, Odermatt B, Hengartner H, Zinkernagel RM.

Proc Natl Acad Sci U S A. 2006 Oct 17;103(42):15535-9. Epub 2006 Oct 9.


Efficacy of quinolones against secondary pneumococcal pneumonia after influenza virus infection in mice.

Hayashi K, Kadowaki SE, Takei M, Fukuda H.

Antimicrob Agents Chemother. 2006 Feb;50(2):748-51.


Proapoptotic effect of proteolytic activation of matrix metalloproteinases by Streptococcus pyogenes thiol proteinase (Streptococcus pyrogenic exotoxin B).

Tamura F, Nakagawa R, Akuta T, Okamoto S, Hamada S, Maeda H, Kawabata S, Akaike T.

Infect Immun. 2004 Aug;72(8):4836-47.


Genome sequence of an M3 strain of Streptococcus pyogenes reveals a large-scale genomic rearrangement in invasive strains and new insights into phage evolution.

Nakagawa I, Kurokawa K, Yamashita A, Nakata M, Tomiyasu Y, Okahashi N, Kawabata S, Yamazaki K, Shiba T, Yasunaga T, Hayashi H, Hattori M, Hamada S.

Genome Res. 2003 Jun;13(6A):1042-55.

Supplemental Content

Support Center